Simvastatin attenuates disease phenotypes in human induced pluripotent stem cell models of familial Parkinson’s disease through RhoA inhibition
- DOI
- 10.64898/2026.08.26.747232
- Published
- 2026-08-31
- Container
- Not recorded
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 39/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- cautionPublication version: Identified as a preprint; peer review and later versions may change the record.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.64898/2026.08.26.747232,
title = {Simvastatin attenuates disease phenotypes in human induced pluripotent stem cell models of familial Parkinson’s disease through RhoA inhibition},
author = {Schmidt SI and Okarmus J and Ryding M and Skousen IK and Jensen NFB and Christensen EB and Winkelmann LS and Juhl AD and Klæbel M and Blaabjerg M and Freude K and Wüstner D and Wade-Martins R and Ryan B and Meyer M.},
year = {2026},
doi = {10.64898/2026.08.26.747232},
url = {https://doi.org/10.64898/2026.08.26.747232}
}RIS
TY - JOUR TI - Simvastatin attenuates disease phenotypes in human induced pluripotent stem cell models of familial Parkinson’s disease through RhoA inhibition AU - Schmidt SI AU - Okarmus J AU - Ryding M AU - Skousen IK AU - Jensen NFB AU - Christensen EB AU - Winkelmann LS AU - Juhl AD AU - Klæbel M AU - Blaabjerg M AU - Freude K AU - Wüstner D AU - Wade-Martins R AU - Ryan B AU - Meyer M. PY - 2026 DO - 10.64898/2026.08.26.747232 UR - https://doi.org/10.64898/2026.08.26.747232 ER -
APA
SI, S., J, O., M, R., IK, S., NFB, J., EB, C., LS, W., AD, J., M, K., M, B., K, F., D, W., R, W., B, R., & M., M. (2026). Simvastatin attenuates disease phenotypes in human induced pluripotent stem cell models of familial Parkinson’s disease through RhoA inhibition. https://doi.org/10.64898/2026.08.26.747232
Source records
- europe-pmc · retrieved 2026-09-26T01:39:13.633Z